Condition (MeSH)
Psychophysiologic Disorders
ClinicalTrials.gov lists 20 trials for Psychophysiologic Disorders or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Psychophysiologic Disorders itself; the rest are tagged with a narrower condition beneath it.
When did Psychophysiologic Disorders trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 2 |
| 2024 | 2 |
| 2022 | 2 |
| 2021 | 3 |
| 2020 | 1 |
| 2019 | 2 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Psychophysiologic Disorders trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 13 |
| Observational | 6 |
How many Psychophysiologic Disorders trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 5 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
| Completed | 7 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Psychophysiologic Disorders? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Doxepin | 2 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Zhizhu Kuanzhong capsules (ZZKZ) | 1 |
| Benperidol | 1 |
| Paroxetine IR | 1 |
| Topiramate IR | 1 |
| Galantamine ER | 1 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Psychophysiologic Disorders? (248)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evaluation of the first nutritional psychiatry and psychosomatics outpatient clinic: Protocol for a prospective study of an individualized biopsychosocial therapy approach. | PloS one | 2026 | Yes |
| Psychosomatic comorbidity in endometriosis: A multi-center, cross-sectional study identifying an underestimated factor in current medical support. | Journal of psychosomatic research | 2025 | Yes |
| What We Have Learned from Two Decades of Epidemics and Pandemics: A Systematic Review and Meta-Analysis of the Psychological Burden of Frontline Healthcare Workers. | Psychotherapy and psychosomatics | 2021 | Yes |
| Management of functional neurological disorder. | Journal of neurology | 2020 | Yes |
| Management of comorbid mental and somatic disorders in stepped care approaches in primary care: a systematic review. | Family practice | 2019 | Yes |
Showing 5 of 248 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.